The potential impact of routine immunization with inactivated poliovirus vaccine on wild-type or vaccine-derived poliovirus outbreaks in a posteradication setting.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  American Journal of Epidemiology

• Publication date

  2013-11-15

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1093/aje/kwt203PMID 24100955
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• African Region

  2014cited by this paper
• European Region

  2014cited by this paper
• 27 – Poliovirus vaccine—inactivated

  2013cited by this paper
• Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6-9 months in Moradabad, India: a community-based, randomised controlled trial.

  2012cited by this paper
• Randomized controlled study of fractional doses of inactivated poliovirus vaccine administered intradermally with a needle in the Philippines.

  2012cited by this paper
• Meeting of the Strategic Advisory Group of Experts on immunization, April 2012--conclusions and recommendations.

  2012cited by this paper
• Systematic Review of Mucosal Immunity Induced by Oral and Inactivated Poliovirus Vaccines against Virus Shedding following Oral Poliovirus Challenge

  2012influential reference
• Mucosal immunity and poliovirus vaccines: impact on wild poliovirus infection and transmission.

  2011cited by this paper
• Polio vaccines and polio immunization in the pre-eradication era: WHO position paper--recommendations.

  2010cited by this paper
• Polio vaccines and polio immunization in the pre-eradication era: WHO position paper.

  2010cited by this paper
• Randomized controlled clinical trial of fractional doses of inactivated poliovirus vaccine administered intradermally by needle-free device in Cuba.

  2010cited by this paper
• Asymptomatic wild-type poliovirus infection in India among children with previous oral poliovirus vaccination.

  2010cited by this paper
• Repertoire of antibodies against type 1 poliovirus in human sera.

  2010cited by this paper
• Implications of a circulating vaccine-derived poliovirus in Nigeria.

  2010cited by this paper
• Updated recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding routine poliovirus vaccination.

  2009cited by this paper
• Poliovirus vaccine-live

  2008cited by this paper
• Estimating the Extent of Vaccine-Derived Poliovirus Infection

  2008cited by this paper
• Randomized, placebo-controlled trial of inactivated poliovirus vaccine in Cuba.

  2007cited by this paper
• Randomized, Placebo-Controlled Trial of Inactivated Poliovirus Vaccine in Cuba

  2007cited by this paper
• [Burkina Faso].

  2006cited by this paper
• New Strategies for the Elimination of Polio from India

  2006cited by this paper
• Effect of different vaccination schedules on excretion of oral poliovirus vaccine strains.

  2005cited by this paper
• Vaccine-derived polioviruses and the endgame strategy for global polio eradication.

  2005cited by this paper
• A dynamic model of poliomyelitis outbreaks: learning from the past to help inform the future.

  2005cited by this paper
• Antibody persistence against diphtheria, tetanus, pertussis, poliomyelitis and Haemophilus influenzae type b (Hib) in 5-6-year-old children after primary vaccination and first booster with a pentavalent combined acellular pertussis vaccine: immunogenicity and tolerance of a tetravalent combined acel

  2004cited by this paper
• Antibody persistence in five-year-old children who received a pentavalent combination vaccine in infancy

  2002cited by this paper
• Outbreak of Poliomyelitis in Hispaniola Associated with Circulating Type 1 Vaccine-Derived Poliovirus

  2002cited by this paper
• Stopping a polio outbreak in the post-eradication era.

  2001cited by this paper
• Vaccination of infants with a four-dose and a three-dose vaccination schedule.

  1999cited by this paper
• Induction of mucosal immunity by inactivated poliovirus vaccine is dependent on previous mucosal contact with live virus.

  1999cited by this paper
• Outbreak of paralytic poliomyelitis in Albania, 1996: high attack rate among adults and apparent interruption of transmission following nationwide mass vaccination.

  1998cited by this paper
• Outbreaks of paralytic poliomyelitis, 1976-1995.

  1997cited by this paper
• Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of the literature.

  1997cited by this paper
• Inactivated poliovirus vaccine: past and present experience.

  1996cited by this paper
• Circulation of poliovirus during the poliomyelitis outbreak in The Netherlands in 1992-1993.

  1996cited by this paper
• Poliomyelitis outbreak in an unvaccinated community in The Netherlands, 1992-93.

  1994cited by this paper
• Serological evaluation of a simplified immunization schedule using quadruple DPT-polio vaccine in Burkina Faso.

  1993cited by this paper
• Measles and Poliomyelitis

  1993cited by this paper
• Herd immunity: history, theory, practice.

  1993cited by this paper
• The polio epidemic in The Netherlands, 1992/1993.

  1993cited by this paper
• The polio epidemic in The Netherlands, 1992/1993.

  1993cited by this paper
• Inactivated and live, attenuated poliovirus vaccines: mucosal immunity

  1993cited by this paper
• Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease.

  1992influential reference
• Mucosal immunity induced by enhance-potency inactivated and oral polio vaccines.

  1991cited by this paper
• MUCOSAL IMMUNITY INDUCED BY ENHANCED POTENCY INACTIVATED AND ORAL POLIO VACCINES

  1991cited by this paper
• Poliomyelitis outbreak in Israel in 1988: a report with two commentaries.

  1990cited by this paper
• The antibody response of seronegative infants to inactivated poliovirus vaccine of enhanced potency.

  1986cited by this paper
• One-dose immunization against paralytic poliomyelitis using a noninfectious vaccine.

  1984cited by this paper
• The epidemiology of poliomyelitis: enigmas surrounding its appearance, epidemicity, and disappearance.

  1979cited by this paper
• Poliomyelitis epidemic in the Netherlands, 1978.

  1979cited by this paper
• Immunoglobulin response in serum and secretions after immunization with live and inactivated poliovaccine and natural infection.

  1968influential reference
• A study of polio vaccination in infancy: excretion following challenge with live virus by children given killed or living poliovaccine

  1966cited by this paper
• OBSERVED AND EXPECTED POLIOMYELITIS IN THE UNITED STATES, 1958-1961.

  1964cited by this paper
• Limitation of fecal and pharyngeal poliovirus excretion in Salk-vaccinated children. A family study during a type 1 poliomyelitis epidemic.

  1962cited by this paper
• Comparison of the Resistance of the Intestinal Tract to Poliomyelitis virus (Sabin's Strains) in Persons after Naturally and Experimentally Acquired Immunity.

  1961cited by this paper
• The paralytic/infected ratio in a susceptible population during a polio type I epidemic.

  1961cited by this paper
• [Viral excretion and antibody formation after use of a live trivalent poliomyelitis vaccine (Cox-Lederle)].

  1961cited by this paper
• Immunization with live attenuated poliovirus vaccine.

  1961cited by this paper
• Virus Excretion and Antibody Development after Ingestion of Trivalent Live Poliovaccine (Cox-Lederle).

  1961cited by this paper
• Studies on the development of natural immunity to poliomyelitis in Louisiana. V. Passive transfer of polioantibody from mother to fetus, and natural decline and disappearance of antibody in the infant.

  1960cited by this paper
• Studies onthe development of natural immunity to poliomyelitis in Louisiana. IV. Natural infections with polioviruses following immunization with a formalin-inactivated vaccine.

  1959cited by this paper
• Influence of prior active immunization on the presence of poliomyelitis virus in the pharynx and stools of family contacts of patients with paralytic poliomyelitis.

  1958cited by this paper
• OBSERVATIONS ON THE EXCRETION OF TYPE I POLIOVIRUS FROM CASES AND THEIR CONTACTS

  1958cited by this paper
• Studies on the development of natural immunity to poliomyelitis in Louisiana. II. Description and analysis of episodes of infection observed in study group households.

  1957cited by this paper
• Development of neutralizing antibodies against the three types of poliomyelitis virus during an epidemic period; the ratio of inapparent infection to clinical poliomyelitis.

  1953cited by this paper
• THE INCUBATION PERIOD IN EPIDEMIC POLIOMYELITIS

  1942cited by this paper

• Vaccination strategies against wild poliomyelitis in polio-free settings: outbreak risk modelling study and cost-effectiveness analysis

  2025cites this paper
• Review of Poliovirus Transmission and Economic Modeling to Support Global Polio Eradication: 2020–2024

  2024cites this paper
• Insights From Modeling Preventive Supplemental Immunization Activities as a Strategy to Eliminate Wild Poliovirus Transmission in Pakistan and Afghanistan

  2020cites this paper
• Review of poliovirus modeling performed from 2000 to 2019 to support global polio eradication

  2020influential citation
• Evaluation of Secondary Concentration Methods for Poliovirus Detection in Wastewater

  2019cites this paper
• Lessons learned from the 2009–2010 H1N1 outbreak for the management of the 2013 silent polio outbreak

  2018cites this paper
• Mass media effect on vaccines uptake during silent polio outbreak.

  2018cites this paper
• John Enders, Jonas Salk, Albert Sabin and Eradication of Poliomyelitis

  2018cites this paper
• Laboratory Surveillance of Polio and Other Enteroviruses in High-Risk Populations and Environmental Samples

  2017cites this paper
• Scale in Disease Transmission, Surveillance, and Modeling

  2017cites this paper
• Estimation of polio infection prevalence from environmental surveillance data

  2017cites this paper
• The risk of type 2 oral polio vaccine use in post-cessation outbreak response

  2017cites this paper
• Poliovirus and rotavirus detection in water: evaluating and applying environmental surveillance methods

  2017cites this paper
• Quantifying Transmission Heterogeneity Using Both Pathogen Phylogenies and Incidence Time Series

  2017cites this paper
• Development and introduction of inactivated poliovirus vaccines derived from Sabin strains in Japan.

  2016cites this paper
• Modeling the spread of polio in an IPV-vaccinated population: lessons learned from the 2013 silent outbreak in southern Israel

  2016cites this paper
• The Drivers of Acute Seasonal Infectious Diseases.

  2015influential citation
• Polio vaccination: past, present and future.

  2015cites this paper
• Comparing Israeli and Palestinian polio vaccination policies and the challenges of silent entry of wild poliovirus in 2013–14: a ‘natural experiment’

  2015cites this paper
• Immunogenicity and Effectiveness of Routine Immunization With 1 or 2 Doses of Inactivated Poliovirus Vaccine: Systematic Review and Meta-analysis

  2014cites this paper
• Effect of Formaldehyde Inactivation on Poliovirus

  2014cites this paper
• Effect of a single inactivated poliovirus vaccine dose on intestinal immunity against poliovirus in children previously given oral vaccine: an open-label, randomised controlled trial.

  2014cites this paper
• Alternative Inactivated Poliovirus Vaccines Adjuvanted with Quillaja brasiliensis or Quil-A Saponins Are Equally Effective in Inducing Specific Immune Responses

  2014cites this paper
• Polio Eradication in India: Need to Switch over to IPV from OPV

  2014cites this paper
• Polio: The eradication endgame

  2014cites this paper
• Effect of formaldehyde inactivation on poliovirus 1 2

  2014influential citation